Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program

Blood (2008) 112 (11): 2680.

https://doi.org/10.1182/blood.V112.11.2680.2680

Published: 2008

Journal Articles

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

Enrico Orciuolo, Gabriele Buda, E. Mauro, E. Marturano, Domenico Pastore, Paola Della Cioppa, Giuseppe Pietrantuono, Letizia Lombardini, Nicola Di Renzo, MD, Giuseppe Irrera, MD, Clotilde Cangialosi, Marino Brunori, Mario Petrini, MD

Blood (2008) 112 (11): 4135.

https://doi.org/10.1182/blood.V112.11.4135.4135

Published: 2008

Journal Articles

The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin’s Lymphoma.

Filippo Russo, MD, Gino Svanera, MD, Paola Della Cioppa, MD, Gaetano Corazzelli, MD, Ferdinando Frigeri, MD, Gaetana Capobianco, MD, Secondo LaStoria, MD, Antonio Pinto, MD

Blood (2005) 106 (11): 2671.

https://doi.org/10.1182/blood.V106.11.2671.2671

Published: 2005

Journal Articles

Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.

Gaetano Corazzelli, MD, Filippo Russo, MD, Gaetana Capobianco, MD, Gianpaolo Marcacci, MD, Paola Della Cioppa, MD, Antonio Pinto, MD

Blood (2005) 106 (11): 940.

https://doi.org/10.1182/blood.V106.11.940.940

Published: 2005

Journal Articles

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

Maria Luigia Vigliotti, MD, Giuseppe Cascini, MD, Ferdinando Frigeri, MD, Anna De Chiara, MD, Paola Della Cioppa, MD, Filomena Oliviero, MD, Secondo Lastoria, MD, Antonio Pinto, MD

Blood (2005) 106 (11): 1001.

https://doi.org/10.1182/blood.V106.11.1001.1001

Published: 2005

NARROW

5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin’s Lymphoma.

Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin’s Lymphoma.

Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.

Intensity of 18 Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only